FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

385151008: Conventional release nasal ointment (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1479414015 Nasal ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3538233018 Conventional release nasal ointment (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3538234012 Conventional release nasal ointment en Synonym Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release nasal ointment Is a Nasal dose form true Inferred relationship Existential restriction modifier
Conventional release nasal ointment Is a Ointment false Inferred relationship Existential restriction modifier
Conventional release nasal ointment Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release nasal ointment Has dose form intended site Nasal true Inferred relationship Existential restriction modifier
Conventional release nasal ointment Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release nasal ointment Has basic dose form Ointment true Inferred relationship Existential restriction modifier
Conventional release nasal ointment Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment Has manufactured dose form False Conventional release nasal ointment Inferred relationship Existential restriction modifier
Conventional release ear or eye or nose ointment Is a True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment 5 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment (Tetris Pharma Ltd) 5 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment (Tetris Pharma Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment Has manufactured dose form False Conventional release nasal ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment Has manufactured dose form False Conventional release nasal ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment Has manufactured dose form False Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (GlaxoSmithKline) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Waymade Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Dowelhurst Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment (PI) (Dowelhurst Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Doncaster Pharmaceuticals Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Sigma Pharmaceuticals Plc) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Lexon (UK) Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Stephar (U.K.) Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Necessity Supplies Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release nasal ointment Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Menthol 0.3% ointment Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Generic Gencydo ointment Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Nostroline 0.3% ointment (Co-Pharma Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Gencydo ointment (Weleda (UK) Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (GlaxoSmithKline) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Lexon (UK) Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Dowelhurst Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Sigma Pharmaceuticals Plc) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Doncaster Pharmaceuticals Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Stephar (U.K.) Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Waymade Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment (PI) (Dowelhurst Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Necessity Supplies Ltd) Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (GlaxoSmithKline) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Menthol 0.3% ointment 14 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Nostroline 0.3% ointment (Co-Pharma Ltd) 14 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Generic Gencydo ointment 25 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Gencydo ointment (Weleda (UK) Ltd) 25 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Waymade Ltd) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (PI) (Dowelhurst Ltd) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Mupirocin 2% nasal ointment (PI) (Dowelhurst Ltd) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Doncaster Pharmaceuticals Ltd) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Sigma Pharmaceuticals Plc) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Lexon (UK) Ltd) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Mawdsley-Brooks & Company Ltd) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Stephar (U.K.) Ltd) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Bactroban 2% nasal ointment (Necessity Supplies Ltd) 3 gram Has dispensed dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Menthol 0.3% ointment Has manufactured dose form False Conventional release nasal ointment Inferred relationship Existential restriction modifier
Generic Gencydo ointment Has manufactured dose form False Conventional release nasal ointment Inferred relationship Existential restriction modifier
Nostroline 0.3% ointment (Co-Pharma Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier
Gencydo ointment (Weleda (UK) Ltd) Has manufactured dose form True Conventional release nasal ointment Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start